136
Participants
Start Date
October 1, 2023
Primary Completion Date
April 1, 2024
Study Completion Date
April 1, 2024
Transorbital Sonography
OND and ONSD of participants in the MS patient group and healthy control group were measured by TOS.
Orbita Magnetic Resonance Imaging
OND and ONSD of participants in the MS patient group were measured by orbita MRI.
Visual Evoked Potentials
P100 amplitude and P100 latency values of participants in the MS patient group were measured by VEP.
Optical Coherence Tomography
pRNFL thickness of participants in the MS patient group were measured by OCT.
Kutahya Health Sciences University, Faculty of Medicine, Kütahya
Kutahya Health Sciences University
OTHER